U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is facing backlash after firing all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) and replacing them with eight new members, several of whom have histories of vaccine skepticism. The move has raised concerns among public health experts and lawmakers, including Senator Bill Cassidy, a Republican and physician from Louisiana who chairs the Senate Health Committee.
Cassidy had previously supported Kennedy's confirmation after receiving assurances that the ACIP structure would remain intact. “If confirmed, he will maintain the CDC’s ACIP without changes,” Cassidy had said during a Senate floor speech. However, Kennedy now says he only promised to let Cassidy choose one candidate for the panel, a pledge he intends to honor.
During a Fox News interview, Kennedy denied violating any agreement. “I told Senator Cassidy I would allow him to put one of his candidates on, which we’re going to do,” he stated. Cassidy’s office later clarified the commitment was about maintaining the ACIP process, not preventing staff changes.
Kennedy defended his decision, citing alleged conflicts of interest among the previous members, though he offered no specific evidence. His reshuffle has drawn sharp criticism from the American Medical Association, which called for an investigation and a reversal of the firings. Critics argue that stacking the panel with vaccine skeptics could undermine public trust in immunization policy.
The ACIP plays a key role in advising the CDC on who should receive vaccines after FDA approval. The controversy has intensified scrutiny of Kennedy’s long-standing views on vaccines, which often contradict mainstream medical consensus. With political and public health stakes high, the debate over ACIP’s direction is far from over.


California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Sydney Bondi Beach Shooting Sparks Calls for Stronger Protection of Jewish Community in Australia
Federal Judge Declines to Immediately Halt Trump’s $300 Million White House Ballroom Project
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Trump Announces $1,776 Cash Bonus for U.S. Military Personnel Ahead of Christmas
Trump Administration Plans Major Increase in Denaturalization Cases for Naturalized U.S. Citizens
Honduras Election Recount Delayed Amid Protests and Political Tensions
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 



